Glymphatic Function as a Prognostic Biomarker in Prolonged Disorders of Consciousness
CNS Neuroscience & Therapeutics · 2025
DOI: 10.1111/cns.70526 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2025. Verfasst von Dian-Wei Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Xijing Hospital, Fourth Military Medical University, Xi'an, China. Hauptthemen laut MEDLINE: Consciousness Disorders, Glymphatic System. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Research and Development Projects of Shaanxi Province.
Abstract (Originalsprache)
Objective
The glymphatic system is a major waste clearance system in the central nervous system. We aim to investigate the glymphatic function and its prognostic values in patients with prolonged disorders of consciousness (pDoC).
Methods
We conducted a prospective and explorative cohort study including 40 patients with pDoC and 20 healthy controls. Glymphatic function was measured with the global and regional blood‐oxygen‐level‐dependent and cerebrospinal fluid (BOLD‐CSF) couplings, characterized by time‐lags and strengths of the couplings. The clinical outcome was defined as improvement and no improvement in consciousness 6 months after enrollment, determined via a structured telephone follow‐up based on the Coma Recovery Scale‐Revised (CRS‐R) score.
Results
Patients with pDoC exhibited significantly delayed time‐lags in BOLD‐CSF coupling ( p < 0.05) and significantly reduced coupling strengths ( p < 0.05) when compared to healthy controls. Follow‐up studies indicated that shorter global BOLD‐CSF coupling time‐lags can predict an improved consciousness 6 months after enrollment, with an area under the receiver operating characteristic curve of 0.837, a sensitivity of 82.4%, and an accuracy of 85.7% using a cutoff point of 7.5.
Conclusion
The glymphatic system was impaired in patients with pDoC, and its function, measured by BOLD‐CSF coupling, can serve as a novel prognostic biomarker.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
ORCID-Profile: Dian-Wei Wu, Chang-Geng Song, Ying-Chi Zhang, Zhong-Qing Sun, Wen Jiang
Förderung
- National Natural Science Foundation of China
- Key Research and Development Projects of Shaanxi Province
Zitieren
APA
Wu, D. W., Song, C. G., Chen, R., Zhao, J. J., Zhang, Y. C., Wang, X., Sun, Z. Q., Kang, X. G., Gao, Q., & Jiang, W. (2025). Glymphatic Function as a Prognostic Biomarker in Prolonged Disorders of Consciousness. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70526
Vancouver
Wu DW, Song CG, Chen R, Zhao JJ, Zhang YC, Wang X, et al. Glymphatic Function as a Prognostic Biomarker in Prolonged Disorders of Consciousness. CNS Neuroscience & Therapeutics. 2025. doi:10.1111/cns.70526
BibTeX
@article{Wu2025,
author = {Wu, Dian-Wei and Song, Chang-Geng and Chen, Rong and Zhao, Jing-Jing and Zhang, Ying-Chi and Wang, Xuan and Sun, Zhong-Qing and Kang, Xiao-Gang and Gao, Qiong and Jiang, Wen},
title = {Glymphatic Function as a Prognostic Biomarker in Prolonged Disorders of Consciousness},
journal = {CNS Neuroscience & Therapeutics},
year = {2025},
doi = {10.1111/cns.70526}
}
EUVIMED